Biological E - About the company
Biological E is a funded company based in Hyderabad (India), founded in 1953 by G A N Raju and Datla Venkata Krishnam Raju. It operates as a Developer of vaccines for treating multiple diseases. Biological E has raised an undisclosed amount in funding. The company has 198 active competitors, including 13 funded and 53 that have exited. Its top competitors include companies like Bayer, Wockhardt and Cipla.
Company Details
Developer of vaccines for treating multiple diseases. It is a globally focused biopharmaceutical company that develops, manufactures, and markets innovative vaccines, branded generics, and novel therapeutics. The product pipeline includes pneumococcal conjugate vaccine, Hib vaccine, Poliomyelitis Vaccine, COVID-19 Vaccine, Hepatitis A, and Measles Vaccine.
- Website
- www.biologicale.com
- Email ID
- *****@biologicale.com
- Phone Number
- +91 **********
- Registered Address
- 18/1 AND 3,AZAMABAD, HYDERABAD, ANDHRA PRADESH, Telangana, India, 500020
Key Metrics
Founded Year
1953
Location
Hyderabad, India
Stage
Funding Raised
Latest Funding Round
Ranked
3rd among 198 active competitors
Annual Revenue
₹1,000+ Cr as on Mar 31, 2025
Employee Count
6,099 as on Jan 31, 2025
Investment & Acquisitions
Legal entities associated with Biological E
Biological E is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
BIOLOGICAL E. LIMITED CIN: U01120TG1953PLC001095 , India, Active | Dec 10, 1953 | ₹1,000+ Cr (As on Mar 31, 2025) | 6536 (As on Mar 01, 2026) |
Sign up to download Biological E's company profile
Biological E's funding and investors
Biological E has raised funding over 4 rounds. Its first funding round was on 2020. Its latest funding round was a Conventional Debt round on Oct 24, 2021 for $*****. 1 investor participated in its latest round. Biological E has 5 institutional investors.
Here is the list of recent funding rounds of Biological E:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Oct 24, 2021 | 9682832 | Conventional Debt | 7961830 | 1948175 | 3027194 | 3005144 |
Dec 29, 2020 | 3939203 | Grant (prize money) | 9966413 | 1955504 | 6592224 | |
Dec 18, 2020 | 2871315 | Conventional Debt | 4003309 | 3825772 | 7707397 |
View details of Biological E's funding rounds and investors
Biological E's founders and board of directors
Founder? Claim ProfileThe founders of Biological E are G A N Raju and Datla Venkata Krishnam Raju. Mahima Datla is the CEO of Biological E.
Here are the details of Biological E's key team members:
- G A N Raju: Former Co-Founder of Biological E.
- Datla Venkata Krishnam Raju: Former Co-Founder of Biological E.
View details of Biological E's Founder profiles and Board Members
Biological E's employee count trend
Biological E has 6,099 employees as of Jan 25. The total employee count is 8.0% more than what it was in Jan 24. Here is Biological E's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Biological E's Competitors and alternates
Top competitors of Biological E include Bayer, Wockhardt and Cipla. Here is the list of Top 10 competitors of Biological E, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Manufacturer of drugs | - | 76/100 | ||
2nd | Manufacturer of pharmaceuticals, biotechnology products, and active pharmaceutical ingredients | - | 71/100 | ||
3rd | Biological E 1953, Hyderabad (India), Funding Raised | Developer of vaccines for treating multiple diseases | - | 69/100 | |
4th | Manufacturer of APIs, generic drugs, and formulation development services | - | 69/100 | ||
5th | Developer, manufacturer, and markets a broad range of pharmaceutical products | $50M | 68/100 | ||
6th | Amneal 2002, Bridgewater (United States), Public | Manufacturer of generics formulations | - | 68/100 | |
7th | Strides Pharma Science 1990, Bengaluru (India), Public | Manufacturer of generic pharmaceutical products and various specialty medical formulations | - | 68/100 | |
8th | Manufacturer of pharmaceutical products, including generics, biosimilars, and active pharmaceutical ingredients | - | 67/100 | ||
9th | Aurobindo Pharma 1986, Hyderabad (India), Public | Provider of generic biocatalytic products | - | 66/100 | |
10th | Dr. Reddy's Laboratories 1984, Hyderabad (India), Public | Multinational pharmaceutical company that develops and manufactures innovative and medicines to improve patient health | - | 65/100 |
Looking for more details on Biological E's competitors? Click here to see the top ones
Biological E's Investments and acquisitions
Biological E has made 5 investments in companies including Dhruva Space and Recykal. Biological E has also acquired 1 companies including Akorn India.Here is the list of investments & acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Jun 25, 2026 | Investments | 2012 | Hyderabad (India) | |
Feb 25, 2026 | Investments | 2016 | Hyderabad (India) | |
Aug 15, 2025 | Investments | 2021 | Mumbai (India) |
See all investments by Biological E
Reports related to Biological E
Here is the latest report on Biological E's geography:
News related to Biological E
Media has covered Biological E for a total of 6 events in the last 1 year, 2 of them have been about company updates and 1 about partnerships.
•
Eris Lifesciences COO V Krishnakumar steps down, set to join Biological EMoneycontrol•Sep 11, 2026•Biological E
•
ICMR licenses cancer, vaccine technologies to Emcure, Biological EIndiatimes•Jul 22, 2026•Biological E, Emcure
•
Morgan Stanley initiates talks for Farm brand sale by Azzas 2154Grupoglobo•Jun 23, 2026•Morgan Stanley, Pidilite, Biological E, opryentertainmentgroup and 1 other
•
•
Biological E to produce J&J COVID-19 vaccine in addition to its candidateIndiatimes•Jul 03, 2025•Biological E, Johnson & Johnson
•
Biological E partners with China’s Recbio to manufacture HPV9 vaccine for India, global marketsMoneycontrol•Jul 01, 2025•RecBio, Biological E
•
Bharat Biotech, Biological E among 11 companies to invest Rs 5,445 crore in Green Pharma CityMedical Dialogues•Feb 28, 2025•Bharat Biotech, Biological E
•
Bavarian Nordic partners with Biological E Limited to expand global access to chikungunya vaccineGlobeNewswire•Feb 25, 2025•Bavarian Nordic, Biological E
•
Biological E inks strategic partnership with Bavarian Nordic to expand access of Chikungunya VaccineBioSpectrum India•Feb 25, 2025•Biological E, Bavarian Nordic
•
Takeda and India's Biological E. to accelerate access to dengue vaccine in endemic areasSeeking Alpha•Feb 27, 2024•Takeda, Biological E
Are you a Founder ?
FAQs about Biological E
Explore our recently published companies
- LG Life Sciences - Seoul based, 1947 founded, Deadpooled company
- Zouhall - United Arab Emirates based, Unfunded company
- Webbiit Technologies - Nigeria based, 2012 founded, Unfunded company
- WebClimb Consulting - 2023 founded, Unfunded company
- WebbedIN - Gurugram based, 2014 founded, Unfunded company
- Web Chember - Gujranwala based, 2017 founded, Unfunded company
